According to Meridian Bioscience's latest financial reports and stock price the company's current Operating Margin is 16.31%. At the end of 2022 the company had an Operating Margin of 16.31%.
Year | Operating Margin | Change |
---|---|---|
2022 | 16.31% | -42.68% |
2021 | 28.45% | 21.73% |
2020 | 23.37% | 48.89% |
2019 | 15.70% | 10.36% |
2018 | 14.22% | -21.6% |
2017 | 18.14% | -29.75% |
2016 | 25.83% | -8.61% |
2015 | 28.26% | 2.42% |
2014 | 27.59% | -9.23% |
2013 | 30.40% | 6.12% |
2012 | 28.65% | 12.98% |
2011 | 25.36% | -12.42% |
2010 | 28.95% | -12.97% |
2009 | 33.26% | 1% |
2008 | 32.94% | 10.41% |
2007 | 29.83% | 15.29% |
2006 | 25.88% | 22.76% |
2005 | 21.08% | 27.17% |
2004 | 16.58% | -5.81% |
2003 | 17.60% | 26.18% |
2002 | 13.95% | -152.89% |
2001 | -26.37% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
-70.97% | -535.13% | ๐บ๐ธ USA | |
16.13% | -1.10% | ๐บ๐ธ USA | |
9.94% | -39.06% | ๐บ๐ธ USA | |
16.77% | 2.82% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.